News of the FDA’s approval came after two randomized, double-blind, placebo-controlled studies.
Pfizer touts quick pain relief as the biggest benefit of Zavzpret.
The medication is also said to eliminate moderate to severe headache pain within two hours, with effects lasting for up to 48 hours.Getty Images/Science Photo Library RFPfizer expects migraine sufferers to have access to Zavzpret via a doctor’s prescription starting in July 2023. “As a nasal spray with rapid drug absorption, Zavzpret offers an alternative treatment option for people who need pain relief or cannot take oral medications due to nausea or vomiting, so they can get back to normal function quickly,” the doctor continued.Dr. Randa Jaafar, a New York-based pain management physician, told Fox News Digital that she believes Zavzpret will be a great addition to the current medications used to treat acute migraines.
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
Pfizer wins FDA approval for its migraine nasal sprayPfizer Inc. said Friday the U.S. Food and Drug Administration has approved its migraine nasal spray Zavzpret. The treatment is the first and only calcitonin...
続きを読む »
FDA approves Pfizer's new nasal spray treatment for migrainesThe FDA approved Pfizer's newest drug on the migraine market, Zavzpret (zavegepant), the first and only migraine treatment offered in a nasal spray.
続きを読む »
US FDA approves Pfizer's pain-relief nasal spray for migraineThe U.S. Food and Drug Administration on Friday approved Pfizer Inc's nasal spray for migraine, giving patients access to a potentially fast-acting pain-relief option for headaches.
続きを読む »
US FDA approves Pfizer's nasal spray for migraineThe U.S. Food and Drug Administration on Friday approved Pfizer Inc's nasal spray for migraine, giving patients access to a potentially fast-acting pain-relief option for headaches.
続きを読む »
FDA approves new nasal spray to treat migraine headaches in adults, Pfizer says | CNNThe FDA has approved a new nasal spray as a rapid treatment for migraine pain in adults. The spray may relieve pain and other migraine symptoms as soon as 15 minutes after use, drugmaker Pfizer says.
続きを読む »
Pfizer says the FDA has approved its migraine nasal spray ZavzpretDrugmaker plans to roll out the drug, which it says can relieve migraine symptoms in 30 minutes, to pharmacies in July.
続きを読む »